Healthcare careers for chemists are once again largely based in laboratories, although increasingly there is opportunity to work at the point of care, helping with patient investigation. In an article, author is Sarkar, Mithun, once mentioned the application of 94839-07-3, Name is Benzo[d][1,3]dioxol-5-ylboronic acid, molecular formula is C7H7BO4. Now introduce a scientific discovery about this category, Category: naphthyridines.
Oxazoline and camphor-pyrazole units are introduced on the 1,8-naphthyridine scaffold to access chiral ligands L-1, L-2 and L-3. Metalation of these chiral ligands with Cu(I) and Ag(I) precursors afforded di- and tetranuclear complexes [Cu4I4(L-1)(2)] (1), [Cu4I4(L-2)(2)] (2), [Cu2I2(L-3)] (3), [Cu2I(L-2)(2)](OTf) (4), [Ag-2(L-1)(2)](OTf)(2) (5) and [Ag-4(L-2)(4)Br](OTf)(3) (6), containing [M4Xn] (n= 1,4 and X = Br, I) or [M2Xn] (n = 0, 1, 2 and X = I) core. All complexes are structurally characterized. Naphthyridine-derived ligands reveal bridge-chelate coordination motif and hold two metal centers in close proximity. The tetranuclear complexes are dimer of dinuclear complexes bridged by the halides. Electronic absorption and emission spectra of copper complexes are reported. Catalytic utility of all complexes are examined for asymmetric transformations but they showed poor activity probably due to limited solubility and coordinative saturation at the metal centers. The best results are obtained with [L-3/Cu salt] combination for cyclopropanation of styrene, N-H bond insertion and nitroaldol (Henry) reactions with very low enantioselectivity.
The reactant in an enzyme-catalyzed reaction is called a substrate. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction. 94839-07-3. The above is the message from the blog manager. Category: naphthyridines.
Reference:
1,8-Naphthyridine – Wikipedia,
,1,8-Naphthyridine | C8H6N2 – PubChem